Overview Safety and Efficacy Study of XPF-001 to Treat Pain Following Wisdom Tooth Extraction Status: Completed Trial end date: 2009-12-01 Target enrollment: Participant gender: Summary The purpose of this trial is to determine if XPF-001 is effective for the treatment of pain following third-molar/wisdom tooth extraction. Phase: Phase 2 Details Lead Sponsor: Xenon Pharmaceuticals Inc.